AS

Ambarish Shah

Chief Technology Officer

DiaMedica Therapeutics Inc.

Boyds, Maryland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
DiaMedica Therapeutics Inc.
Industry
research
Employees
37.0
Seniority
C suite
Annual Revenue
4729000.0

Technologies

Microsoft Office 365 Amazon AWS Salesforce Sophos Google Tag Manager Apache Mobile Friendly Remote AI Data Analytics Basis

Keywords

stroke recombinant protein preeclampsia biotech biotechnology: pharmaceutical preparations health care biotechnology research diamedica therapeutics dm199 acute ischemic stroke klk1 protein clinical trials recombinant proteins vasodilation blood flow improvement therapeutic drugs neurological disorders preeclampsia treatment vascular diseases collateral circulation patient outcomes phase 2 trial phase 3 trial disease modifying therapy clinical-stage biopharmaceutical therapeutic modality inflammation reduction oxidative stress maternal health fetal health clinical research investigational drug adaptive trial design safety & efficacy health conditions kallikrein-kinin system angiogenesis promotion blood pressure management neuron protection vascular occlusion fda fast track drug development patient enrollment diagnostic tools hypertensive disorders pharmaceutical innovations therapeutic candidates patient safety medical interventions public health impact dosing protocol clinical endpoints injury mechanisms biopharmaceutical development investor relations health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans